Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.
about
In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.Therapeutic effects of cefpirome (HR 810) on experimental mixed infections with Enterococcus faecalis and Escherichia coli in mice.In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrumIn vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureusDistribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch.Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae.In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.Interaction of beta-lactamases I and II from Bacillus cereus with semisynthetic cephamycins. Kinetic studies.In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.
P2860
Q33977338-78E28BB3-5D86-4179-ACA8-395F8041826EQ34031360-64A176DF-6581-4659-9A17-4E62D80BD9E1Q35126022-D52547CC-B9D1-4FEA-86DC-AD0BE55A8881Q35248754-515C6F40-36D4-418B-844A-68011D49E306Q35884688-8321F535-7FDC-4CE7-A9D6-A548989830C1Q36198315-CFCB8E29-7E0C-4DCC-B0CD-B5164355A060Q36438393-FA4B5EDB-7B2D-4063-8411-A16F4A307887Q36752573-865E8AFF-216A-40C6-8C46-AD5D3350664EQ37218996-4CBFC154-AB74-4D8A-83BB-88B1CA042ABAQ39781064-BCA79604-098E-4BBA-BC5B-8C6CD9B4DFBFQ39815111-F6874B2E-D29C-41F6-BBD3-7341D3091685Q39818182-9465CF14-F49F-41A2-8AC5-0648D868E745Q39875846-04B1DAD0-1CDA-421B-9759-ED47647AA174Q39881805-D2058511-5E09-4D18-AB62-6A0C2D825885Q40088008-625076FC-58E8-428E-83DC-445A975C3D9AQ41808236-C287B4FA-AB70-4C19-9FC2-BF650DA8FF1DQ44580393-E3536452-051A-431C-B1A2-EBAA6351F402Q54158188-333157DB-C2C3-4879-8DCA-00E72801592F
P2860
Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Beta-lactamase stability of ce ...... broad antimicrobial spectrum.
@en
Beta-lactamase stability of ce ...... broad antimicrobial spectrum.
@nl
type
label
Beta-lactamase stability of ce ...... broad antimicrobial spectrum.
@en
Beta-lactamase stability of ce ...... broad antimicrobial spectrum.
@nl
prefLabel
Beta-lactamase stability of ce ...... broad antimicrobial spectrum.
@en
Beta-lactamase stability of ce ...... broad antimicrobial spectrum.
@nl
P2093
P2860
P356
P1476
Beta-lactamase stability of ce ...... broad antimicrobial spectrum.
@en
P2093
P2860
P304
P356
10.1128/AAC.30.5.713
P407
P577
1986-11-01T00:00:00Z